These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23413114)

  • 1. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.
    Cipriani P; Marrelli A; Benedetto PD; Liakouli V; Carubbi F; Ruscitti P; Alvaro S; Pantano I; Campese AF; Grazioli P; Screpanti I; Giacomelli R
    Angiogenesis; 2013 Jul; 16(3):595-607. PubMed ID: 23413114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.
    Cipriani P; Di Benedetto P; Ruscitti P; Campese AF; Liakouli V; Carubbi F; Pantano I; Berardicurt O; Screpanti I; Giacomelli R
    Arthritis Res Ther; 2014 Sep; 16(5):442. PubMed ID: 25248297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis.
    Hegner B; Schaub T; Catar R; Kusch A; Wagner P; Essin K; Lange C; Riemekasten G; Dragun D
    PLoS One; 2016; 11(4):e0153101. PubMed ID: 27054717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.
    Antoon R; Yeger H; Loai Y; Islam S; Farhat WA
    J Biomed Mater Res A; 2012 Jan; 100(1):72-83. PubMed ID: 21972045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
    Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells.
    Liu Y; Deng B; Zhao Y; Xie S; Nie R
    Dev Growth Differ; 2013 Jun; 55(5):591-605. PubMed ID: 23557080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
    Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
    J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.
    Leuning DG; Reinders ME; Li J; Peired AJ; Lievers E; de Boer HC; Fibbe WE; Romagnani P; van Kooten C; Little MH; Engelse MA; Rabelink TJ
    Stem Cells Transl Med; 2017 Feb; 6(2):405-418. PubMed ID: 28191776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An In Vitro Co-Culture Model of Bone Marrow Mesenchymal Stromal Cells and Peripheral Blood Mononuclear Cells Promotes the Differentiation of Myeloid Angiogenic Cells and Pericyte-Like Cells.
    Uusitalo-Kylmälä L; Santo Mendes AC; Polari L; Joensuu K; Heino TJ
    Stem Cells Dev; 2021 Mar; 30(6):309-324. PubMed ID: 33499756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients.
    Virzì F; Bianca P; Giammona A; Apuzzo T; Di Franco S; Mangiapane LR; Colorito ML; Catalano D; Scavo E; Nicotra A; Benfante A; Pistone G; Caputo V; Dieli F; Pirrello R; Stassi G
    Stem Cell Res Ther; 2017 Oct; 8(1):236. PubMed ID: 29058626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Differentiation of Bone Marrow Mesenchymal Stem Cells into Endothelial Cells in Vitro.
    Wang C; Li Y; Yang M; Zou Y; Liu H; Liang Z; Yin Y; Niu G; Yan Z; Zhang B
    Eur J Vasc Endovasc Surg; 2018 Feb; 55(2):257-265. PubMed ID: 29208350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial precursor cells stimulate pericyte-like coverage of bone marrow-derived mesenchymal stem cells through platelet-derived growth factor-BB induction, which is enhanced by substance P.
    Zhang M; Ahn W; Kim S; Hong HS; Quan C; Son Y
    Microcirculation; 2017 Nov; 24(8):. PubMed ID: 28791754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericyte plasticity - comparative investigation of the angiogenic and multilineage potential of pericytes from different human tissues.
    Herrmann M; Bara JJ; Sprecher CM; Menzel U; Jalowiec JM; Osinga R; Scherberich A; Alini M; Verrier S
    Eur Cell Mater; 2016 Apr; 31():236-49. PubMed ID: 27062725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.